---
title: "12 Health Care Stocks Moving In Monday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294740945.md"
description: "In Monday's after-market session, several healthcare stocks moved significantly. Gainers included Ensysce Biosciences (+118.1%), TransCode Therapeutics (+13.74%), and Inspire Medical Systems (+13.0%). Losers featured Addex Therapeutics (-17.6%), ClearPoint Neuro (-16.78%), and SI-BONE (-8.14%). Notably, Q2 earnings reports were released for Inspire Medical Systems, ClearPoint Neuro, and SI-BONE, influencing their price movements."
datetime: "2026-08-03T21:05:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294740945.md)
  - [en](https://longbridge.com/en/news/294740945.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294740945.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Monday's After-Market Session

### Gainers

-   **Ensysce Biosciences** (NASDAQ:ENSC) stock rose 118.1% to $0.61 during Monday's after-market session. The market value of their outstanding shares is at $3.8 million.
-   **TransCode Therapeutics** (NASDAQ:RNAZ) shares rose 13.74% to $4.8. The company's market cap stands at $4.8 million.
-   **Inspire Medical Systems** (NYSE:INSP) stock moved upwards by 13.0% to $59.01. The company's market cap stands at $1.4 billion. As per the news, the Q2 earnings report came out today.
-   **Mira Pharmaceuticals** (NASDAQ:MIRA) stock rose 9.13% to $0.67. The company's market cap stands at $33.2 million.
-   **Nomad Power Solutions** (NASDAQ:NMAD) stock rose 8.83% to $4.68. The company's market cap stands at $81.9 million.
-   **CalciMedica** (NASDAQ:CALC) stock moved upwards by 8.57% to $0.81. The company's market cap stands at $15.7 million.

### Losers

-   **Addex Therapeutics** (NASDAQ:ADXN) shares fell 17.6% to $5.0 during Monday's after-market session. The market value of their outstanding shares is at $6.4 million.
-   **ClearPoint Neuro** (NASDAQ:CLPT) stock fell 16.78% to $12.8. The company's market cap stands at $448.0 million. The company's, Q2 earnings came out today.
-   **SI-BONE** (NASDAQ:SIBN) stock fell 8.14% to $16.95. The market value of their outstanding shares is at $787.6 million. As per the news, the Q2 earnings report came out today.
-   **China SXT Pharmaceuticals** (NASDAQ:SXTC) shares decreased by 7.29% to $0.07. The company's market cap stands at $2.3 million.
-   **rYojbaba** (NASDAQ:RYOJ) stock decreased by 6.48% to $5.2. The market value of their outstanding shares is at $63.2 million.
-   **Moleculin Biotech** (NASDAQ:MBRX) stock fell 6.22% to $0.4. The company's market cap stands at $2.1 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [ENSC.US](https://longbridge.com/en/quote/ENSC.US.md)
- [CLPT.US](https://longbridge.com/en/quote/CLPT.US.md)
- [INSP.US](https://longbridge.com/en/quote/INSP.US.md)
- [SIBN.US](https://longbridge.com/en/quote/SIBN.US.md)
- [ADXN.US](https://longbridge.com/en/quote/ADXN.US.md)
- [RNAZ.US](https://longbridge.com/en/quote/RNAZ.US.md)
- [MIRA.US](https://longbridge.com/en/quote/MIRA.US.md)
- [NMAD.US](https://longbridge.com/en/quote/NMAD.US.md)
- [CALC.US](https://longbridge.com/en/quote/CALC.US.md)
- [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md)
- [RYOJ.US](https://longbridge.com/en/quote/RYOJ.US.md)
- [MBRX.US](https://longbridge.com/en/quote/MBRX.US.md)
- [ENSCW.US](https://longbridge.com/en/quote/ENSCW.US.md)

## Related News & Research

- [SI-BONE Chief Op & Financial Officer Anshul Maheshwari disposes of 16,975 common shares worth $336,788.15](https://longbridge.com/en/news/296656276.md)
- [Inspire Medical Systems (INSP) Stock Trades Below Fair Value As Caution Lingers](https://longbridge.com/en/news/296100205.md)
- [Ensysce Biosciences director Bob G. Gower acquires common shares worth $443,025.17](https://longbridge.com/en/news/296210667.md)
- [Ensysce Biosciences Q2 net loss widens on higher R&D costs](https://longbridge.com/en/news/295841617.md)
- [Amgen Target of Unusually High Options Trading (NASDAQ:AMGN)](https://longbridge.com/en/news/296534196.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**